Cymbalta (Duloxetine Hydrochloride capsules)

The image displays teal-colored capsules with the imprint 'CY 186'. This specific imprint identifies the medication as Duloxetine Hydrochloride 60 mg, a generic equivalent or brand-name version of Cymbalta. Cymbalta is a member of the selective serotonin and norepinephrine reuptake inhibitor (SNRI) class, primarily used to treat major depressive disorder, generalized anxiety disorder, and chronic pain conditions.

Originally developed and patented by Eli Lilly and Company, the brand became one of the most widely prescribed neurological medications in the world. Since the expiration of its patent, numerous generic manufacturers produce these capsules globally, though the primary original production infrastructure remains centered in the United States and Puerto Rico.

Ownership of the brand name resides with Eli Lilly, a major American pharmaceutical corporation headquartered in Indianapolis. Eli Lilly is a global leader in the healthcare industry, known for its extensive research in diabetes, oncology, and neuroscience.